NCT03446079 is a NA clinical trial of Topical Anti Aging Cream in Genetics, sponsored by HelicalCodeMD.

Who is sponsoring NCT03446079?

NCT03446079 is sponsored by HelicalCodeMD.

What drugs are being tested in NCT03446079?

Interventions in NCT03446079: Topical Anti Aging Cream.

What condition does NCT03446079 study?

NCT03446079 studies Genetics, Skin Aging.

Is NCT03446079 still recruiting?

NCT03446079 is currently completed. Last updated 3 July 2023.

Last reviewed 2023-07-03 · How we verify

NCT03446079

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Relationship of Skin Related SNP to Topical Skin Care Product

Completed NA Last updated 3 July 2023

What this trial tests

NA trial testing Topical Anti Aging Cream in Genetics in 156 participants. Completed in 28 December 2022.

Timeline

19 March 2018

Primary endpoint
31 January 2019

28 December 2022

Quick facts

Lead sponsor	HelicalCodeMD
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	156
Start date	19 March 2018
Primary completion	31 January 2019
Estimated completion	28 December 2022
Sites	1 location across United States

Drugs / interventions tested

Topical Anti Aging Cream

Conditions studied

Genetics — all drugs for Genetics →
Skin Aging — all drugs for Skin Aging →

Sponsor

HelicalCodeMD

Who can join

21 and older, any sex, with Genetics or Skin Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Demonstrate the relationship between single nucleotide polymorphisms (SNP) and response to a topical skin care product.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Genetics

Currently open trials in the same condition.

NCT06714058 — Cardiometabolic Risk of Obese Subjects: Cross-sectional Study · recruiting
NCT04024631 — Phenotyping Genetic Risk for Type 2 Diabetes · NA · recruiting
NCT03650829 — IVF Offspring Born in Guangzhou · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03446079 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by HelicalCodeMD
Last refreshed: 3 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03446079.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing